First combined COVID-19 and influenza vaccine for people 50 years and older
First combined COVID-19 and influenza vaccine for people 50 years and older
First combined COVID-19 and influenza vaccine for people 50 years and older
Summary of opinion: Scemblix, 26/02/2026 Positive
Summary of opinion: Stelara, 26/02/2026 Positive
Summary of opinion: Dupixent, 26/02/2026 Positive
Summary of opinion: Keytruda, 26/02/2026 Positive
Info sheet - Orphan medicines in the EU
New medicine to treat paediatric low-grade glioma
Human medicines European public assessment report (EPAR): Flucelvax Tetra, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 12/12/2018, Revision: 17, Status: Withdrawn
Human medicines European public assessment report (EPAR): Evkeeza, evinacumab, Date of authorisation: 17/06/2021, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 20, Status: Authorised